Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 2,113-2,124 of 10,612

Drug study icon

CompletedNCT05848700

A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT03543410

A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression

This study is completed in the United States, in Bulgaria, in Japan, .... It focuses on depression.

In United States

Depression, BipolarityDrugFrom 18 Years to 65 Years

Countries: United States, Bulgaria, Japan, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Depression, Bipolarity

Drug study icon

CompletedNCT00554177

A study for PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Antonia New
Condition: PTSD

Drug study icon

TerminatedNCT05753007

A study of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyDrugOver 18 Years

Countries: United States
Sponsor: Mclean Hospital
Condition: Anxiety

Drug study icon

CompletedNCT00571922

A study of Acamprosate for Treatment of Methamphetamine Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 99 Years

Countries: United States
Sponsor: NYU Langone Health
Condition: Addiction

Drug study icon

CompletedNCT03460756

A study of Oral Ganaxolone in Women With Postpartum Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 48 Years

Countries: United States
Sponsor: Marinus Pharmaceuticals
Condition: Depression

Drug study icon

TerminatedNCT05260541

A study of PRAX-114 in people with PTSD

This study was terminated in the United States. It focuses on PTSD.

In United States

PTSDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Praxis Precision Medicines
Condition: PTSD

Drug study icon

Active Not RecruitingNCT05624528

A study of Tolcapone in OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Chicago
Condition: OCD

Drug study icon

CompletedNCT04865835

A study Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia.

This study is completed in the United States. It focuses on schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT04092686

Investigational Drug for schizophrenia

This study is completed in the United States, in Bulgaria, in Croatia, .... It is testing investigational Drug for schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, Bulgaria, Croatia, ...
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Behavioral study icon

CompletedNCT05857956

A study to Assess the Efficacy of a Plant-based Energy Shot on Focus and ADHD-like Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHD, AnxietyBehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: Proper Wild, Inc.
Condition: ADHD, Anxiety

Behavioral study icon

CompletedNCT06505694

A study to Assess the Impact of an Alcohol Alternative Herbal Tincture on Signs of Stress Anxiety and Sleep Quality.

This study is completed in the United States. It focuses on anxiety.

In United States

AnxietyBehavioralFrom 21 Years to 65 Years

Countries: United States
Sponsor: Apothekary
Condition: Anxiety

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.